paclitaxel has been researched along with Cranial Nerve II Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Etminan, M; Maberley, D; Mikelberg, F; Sodhi, M; Yeung, SN | 1 |
| Adams, S; Goldberg, NR; Park, E | 1 |
| Capri, G; Caraceni, A; Fulfaro, F; Gianni, L; Martini, C; Munzone, E; Scaioli, V; Tarenzi, E | 1 |
3 other study(ies) available for paclitaxel and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Bridged-Ring Compounds; Child; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Macular Edema; Middle Aged; Optic Nerve Diseases; Paclitaxel; Retrospective Studies; Tamoxifen; Taxoids | 2022 |
Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy.
Topics: Aged; Albumins; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Humans; Macular Edema; Optic Nerve Diseases; Paclitaxel | 2016 |
Optic nerve disturbances: a new form of paclitaxel neurotoxicity.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Optic Nerve Diseases; Paclitaxel | 1994 |